MX2024013592A - Sistemas multicomponentes para modificaciones del genoma en sitios especificos - Google Patents
Sistemas multicomponentes para modificaciones del genoma en sitios especificosInfo
- Publication number
- MX2024013592A MX2024013592A MX2024013592A MX2024013592A MX2024013592A MX 2024013592 A MX2024013592 A MX 2024013592A MX 2024013592 A MX2024013592 A MX 2024013592A MX 2024013592 A MX2024013592 A MX 2024013592A MX 2024013592 A MX2024013592 A MX 2024013592A
- Authority
- MX
- Mexico
- Prior art keywords
- expression
- methods
- introduction
- systems
- site
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
- A61K48/0058—Nucleic acids adapted for tissue specific expression, e.g. having tissue specific promoters as part of a contruct
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/102—Mutagenizing nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
- C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
- C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1241—Nucleotidyltransferases (2.7.7)
- C12N9/1276—RNA-directed DNA polymerase (2.7.7.49), i.e. reverse transcriptase or telomerase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
- C12Y207/07—Nucleotidyltransferases (2.7.7)
- C12Y207/07049—RNA-directed DNA polymerase (2.7.7.49), i.e. telomerase or reverse-transcriptase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/33—Chemical structure of the base
- C12N2310/335—Modified T or U
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/22—Vectors comprising a coding region that has been codon optimised for expression in a respective host
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/40—Systems of functionally co-operating vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/50—Vector systems having a special element relevant for transcription regulating RNA stability, not being an intron, e.g. poly A signal
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263337564P | 2022-05-02 | 2022-05-02 | |
| PCT/US2023/066470 WO2023215727A2 (en) | 2022-05-02 | 2023-05-02 | Multicomponent systems for site-specific genome modifications |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2024013592A true MX2024013592A (es) | 2025-02-10 |
Family
ID=88647154
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2024013592A MX2024013592A (es) | 2022-05-02 | 2024-11-01 | Sistemas multicomponentes para modificaciones del genoma en sitios especificos |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250049960A1 (https=) |
| EP (1) | EP4519424A4 (https=) |
| JP (1) | JP2025517630A (https=) |
| KR (1) | KR20250006975A (https=) |
| CN (1) | CN119630786A (https=) |
| AU (1) | AU2023264067A1 (https=) |
| CA (1) | CA3251169A1 (https=) |
| IL (1) | IL316725A (https=) |
| MX (1) | MX2024013592A (https=) |
| WO (1) | WO2023215727A2 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025264587A1 (en) * | 2024-06-17 | 2025-12-26 | Addition Therapeutics, Inc. | Rna tails for target primed reverse transcription |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1622574A4 (en) * | 2003-04-25 | 2006-10-18 | Medimmune Vaccines Inc | EXPRESSION SYSTEMS OF RECOMBINANT PARAINFLUENZA VIRUSES AND VACCINES COMPRISING HETEROLOGOUS ANTIGENS DERIVED FROM METAPNEUMOVIRUS |
| EP3844272A1 (en) * | 2018-08-28 | 2021-07-07 | Flagship Pioneering Innovations VI, LLC | Methods and compositions for modulating a genome |
| US20220298495A1 (en) * | 2019-06-12 | 2022-09-22 | Emendobio Inc. | Novel genome editing tool |
| KR20230053735A (ko) * | 2020-03-04 | 2023-04-21 | 플래그쉽 파이어니어링 이노베이션스 브이아이, 엘엘씨 | 게놈의 조정을 위한 개선된 방법 및 조성물 |
| EP4153738A1 (en) * | 2020-05-20 | 2023-03-29 | Commissariat à l'Energie Atomique et aux Energies Alternatives | In-cell continuous target-gene evolution, screening and selection |
| CN116745428A (zh) | 2021-01-14 | 2023-09-12 | 加利福尼亚大学董事会 | 位点特异性基因修饰 |
-
2023
- 2023-05-02 KR KR1020247039844A patent/KR20250006975A/ko active Pending
- 2023-05-02 EP EP23800161.4A patent/EP4519424A4/en active Pending
- 2023-05-02 WO PCT/US2023/066470 patent/WO2023215727A2/en not_active Ceased
- 2023-05-02 CA CA3251169A patent/CA3251169A1/en active Pending
- 2023-05-02 AU AU2023264067A patent/AU2023264067A1/en active Pending
- 2023-05-02 IL IL316725A patent/IL316725A/en unknown
- 2023-05-02 CN CN202380051164.4A patent/CN119630786A/zh active Pending
- 2023-05-02 JP JP2024564803A patent/JP2025517630A/ja active Pending
-
2024
- 2024-10-26 US US18/928,020 patent/US20250049960A1/en active Pending
- 2024-11-01 MX MX2024013592A patent/MX2024013592A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2023215727A2 (en) | 2023-11-09 |
| IL316725A (en) | 2024-12-01 |
| AU2023264067A1 (en) | 2024-11-28 |
| WO2023215727A3 (en) | 2024-04-18 |
| EP4519424A2 (en) | 2025-03-12 |
| EP4519424A4 (en) | 2025-09-24 |
| CN119630786A (zh) | 2025-03-14 |
| CA3251169A1 (en) | 2023-11-09 |
| JP2025517630A (ja) | 2025-06-10 |
| KR20250006975A (ko) | 2025-01-13 |
| US20250049960A1 (en) | 2025-02-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7698828B2 (ja) | Rnaを編集する方法および組成物 | |
| US20240336892A1 (en) | Compositions and methods for the induction and tuning of gene expression | |
| Chen et al. | Decorating chromatin for enhanced genome editing using CRISPR-Cas9 | |
| Proudfoot | Ending the message: poly (A) signals then and now | |
| US9957505B2 (en) | Polynucleotides for multivalent RNA interference, compositions and methods of use thereof | |
| CA3196116A1 (en) | Systems, methods, and compositions for site-specific genetic engineering using programmable addition via site-specific targeting elements (paste) | |
| JP7473969B2 (ja) | 固定ガイドrnaペアを用いた遺伝子編集ベクターの作製方法 | |
| Reautschnig et al. | Precise in vivo RNA base editing with a wobble-enhanced circular CLUSTER guide RNA | |
| O’Prey et al. | Application of CRISPR/Cas9 to autophagy research | |
| KR20150083115A (ko) | 리보조절인자 조성물 및 사용 방법 | |
| JP2021529518A5 (https=) | ||
| WO2016130697A1 (en) | Methods and kits for generating vectors that co-express multiple target molecules | |
| MX2024013592A (es) | Sistemas multicomponentes para modificaciones del genoma en sitios especificos | |
| WO2021243289A1 (en) | Systems and methods for stable and heritable alteration by precision editing (shape) | |
| CN114144519B (zh) | 单碱基置换蛋白以及包含其的组合物 | |
| KR20230135630A (ko) | 유전자 전사 프레임워크, 벡터 시스템, 게놈 서열 편집 방법 및 응용 | |
| EP4688872A1 (en) | Click-to-install genome editing | |
| JP7031893B2 (ja) | ゲノム編集酵素の活性を阻害する核酸アプタマー | |
| KR102638799B1 (ko) | CRISPR/Cas12f1(Cas14a1) system 효율화를 위한 engineered guide RNA 및 이의 용도 | |
| Skowron et al. | An efficient method for the construction of artificial, concatemeric DNA, RNA and proteins with genetically programmed functions, using a novel, vector-enzymatic DNA fragment amplification-expression technology | |
| AU784832B2 (en) | Self-cleaving RNA sequences and their use for the control of protein synthesis | |
| KR20240136988A (ko) | 스트렙토코커스 피오게네스 유래 Cas9 변이체 | |
| Liao et al. | CRATES: A one-step assembly method for Class 2 CRISPR arrays | |
| WO2022216804A3 (en) | Specific oligonucleotide-programmed readthrough of nonsense codons | |
| US20250354177A1 (en) | System and methods for duplicating target fragments |